|
| Arm A (N = 30) | Arm B (N = 30) | p* (Chi square) | Sig. | |
| Age Groups | <60 years | 22 (73.3%) | 18 (60%) |
0.243
|
NS |
| ≥60 years | 8 (26.7%) | 12 (40.0%) | |||
| Sex | Male | 27 (90.0%) | 25 (83.3%) | 0.448 | NS |
| Female | 3 (10.0%) | 5 (16.7%) | |||
| Performance status | 0 | 5 (16.7%) | 8 (26.7%) | 0.403 | NS
|
| 1 | 16 (53.3%) | 11 (36.7%) | |||
| 2 | 9 (30.0%) | 11 (36.7%) | |||
| Pathology |
|
|
| 0.707 | NS |
| Squamous | 27 (90%) | 26 (86.7%) | |||
| Large cell | 3 (10%) | 4 (13.3%) | |||
| TNM Stage | IIIB | 18 (60%) | 14 (46.7%) | 0.301 | NS |
| IV | 12 (40%) | 16 (53.3%) | |||
| Site of metastases | Lung | 7 (23.3%) | 5 (16.7%) | 0.519 | NS |
| Bone | 13 (43.3%) | 11 (36.7%) | 0.598 | NS | |
| Liver | 7 (23.3%) | 5 (16.7%) | 0.519 | NS | |
| Suprarenal | 3 (10%) | 1 (3.3%) | 0.301 | NS | |
| Scalp | 1 (3.3%) | 0 (0.0%) | 0.313 | NS | |